X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
cardiac & cardiovascular systems (21) 21
index medicus (19) 19
female (18) 18
middle aged (17) 17
male (16) 16
aged (15) 15
stents (11) 11
treatment outcome (10) 10
acute myocardial infarction (9) 9
angioplasty (7) 7
cardiovascular diseases (7) 7
clopidogrel (7) 7
myocardial infarction (7) 7
restenosis (7) 7
thrombosis (7) 7
analysis (6) 6
percutaneous coronary intervention (6) 6
risk factors (6) 6
stent (6) 6
acute coronary syndromes (5) 5
coronary restenosis (5) 5
drug-eluting stents (5) 5
endothelialization (5) 5
follow-up studies (5) 5
heart attack (5) 5
heart attacks (5) 5
implants (5) 5
in-stent restenosis (5) 5
mortality (5) 5
myocardial infarction - therapy (5) 5
percutaneous coronary intervention - adverse effects (5) 5
peripheral vascular disease (5) 5
progenitor cells (5) 5
time factors (5) 5
abridged index medicus (4) 4
angioplasty, balloon, coronary (4) 4
atherosclerosis (4) 4
biomedical engineering (4) 4
cardiovascular (4) 4
care and treatment (4) 4
coronary angiography (4) 4
coronary artery disease (4) 4
coronary artery disease - diagnostic imaging (4) 4
disease (4) 4
drug-eluting stent (4) 4
electrocardiography (4) 4
equipment and supplies (4) 4
in-vitro (4) 4
intervention (4) 4
myocardial infarction - surgery (4) 4
nanoparticles (4) 4
optical coherence tomography (4) 4
paclitaxel (4) 4
patients (4) 4
polymorphism, genetic (4) 4
registries (4) 4
surgical implants (4) 4
surgical procedures, operative (4) 4
ticagrelor (4) 4
aspirin (3) 3
blood (3) 3
cardiology (3) 3
catheters (3) 3
drug-delivery (3) 3
endothelial cells (3) 3
endothelium (3) 3
equipment design (3) 3
genetic aspects (3) 3
genotype (3) 3
healing (3) 3
hematopoietic stem-cells (3) 3
implantation (3) 3
infarction (3) 3
magnetic fields (3) 3
magnetic stent (3) 3
management (3) 3
medical emergencies. critical care. intensive care. first aid (3) 3
metals (3) 3
percutaneous coronary intervention - instrumentation (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
polyurethane (3) 3
primary pci (3) 3
prospective studies (3) 3
prosthesis design (3) 3
randomized-trial (3) 3
risk (3) 3
stent thrombosis (3) 3
swine (3) 3
therapy (3) 3
transplantation (3) 3
trial (3) 3
acute coronary syndrome (2) 2
adenosine (2) 2
adult (2) 2
aged, 80 and over (2) 2
alleles (2) 2
angioplasty, balloon, coronary - adverse effects (2) 2
animals (2) 2
antimitotic agents (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 06/2018, Volume 71, Issue 23, pp. 2711 - 2712
Journal Article
Current vascular pharmacology, 02/2018
Various antiplatelet drugs are used following acute coronary syndromes (ACS). Of them, adenosine diphosphate receptor P2Y12 inhibitors clopidogrel, prasugrel... 
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2018, Volume 71, Issue 4, pp. 371 - 381
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2018, Volume 71, Issue 23, pp. 2711 - 2712
Journal Article
BMC Cardiovascular Disorders, ISSN 1471-2261, 06/2017, Volume 17, Issue 1, pp. 168 - 9
Background: Our study aimed to compare the efficacy of seal-wing paclitaxel-eluting balloon catheters (PEB) with iopromide-coated PEB and everolimus-eluting... 
In-stent restenosis | Paclitaxel-elution balloon | Drug-eluting stent | CARDIAC & CARDIOVASCULAR SYSTEMS | LONG-TERM DURATION | ALL-COMER PATIENTS | INDUCED INTIMAL HYPERPLASIA | 2-YEAR OUTCOMES | TRIAL | PERCUTANEOUS CORONARY INTERVENTION | THERAPY | DUAL-ANTIPLATELET TREATMENT | END-POINTS | PRODIGY | Recurrence | Angioplasty, Balloon, Coronary - instrumentation | Prospective Studies | Humans | Metals | Middle Aged | Male | Prosthesis Design | Case-Control Studies | Angioplasty, Balloon, Coronary - adverse effects | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Odds Ratio | Paclitaxel - administration & dosage | Stents | Coronary Restenosis - etiology | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Risk Factors | Kaplan-Meier Estimate | Paclitaxel - adverse effects | Logistic Models | Treatment Outcome | Cardiac Catheters | Coated Materials, Biocompatible | Coronary Restenosis - diagnostic imaging | Coronary Restenosis - therapy | Randomized Controlled Trials as Topic | Coronary Angiography | Disease-Free Survival | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Aged | Cardiovascular Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Antimitotic agents | Antineoplastic agents | Stent (Surgery) | Contrast media | Intervention | Restenosis | Medical imaging | Heart attacks | Angioplasty | Implants | Paclitaxel | Diabetes | Prodigies | Heart diseases | Catheters
Journal Article
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue 21, pp. 1603 - 1612
Journal Article
Circulation, ISSN 0009-7322, 09/2017, Volume 136, Issue 11, pp. 1007 - 1021
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A16218 - A16218
BackgroundThe prognostic significance of periprocedural myocardial infarction (MI) remains controversial.PurposeThe study aims to evaluate the incidence of... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.